Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Status:
NOT_YET_RECRUITING
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.
Phase:
PHASE3
Details
Lead Sponsor:
University of Virginia
Collaborators:
Children's National Research Institute Massachusetts General Hospital Medical University of South Carolina University of Michigan